Champlain Investment Partners’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $174M | Sell |
|
|||||
|
2025
Q1 | $189M | Sell |
|
|||||
|
2024
Q4 | $209M | Sell |
|
|||||
|
2024
Q3 | $203M | Buy |
|
|||||
|
2024
Q2 | $272M | Sell |
|
|||||
|
2024
Q1 | $283M | Buy |
|
|||||
|
2023
Q4 | $219M | Buy |
|
|||||
|
2023
Q3 | $192M | Sell |
|
|||||
|
2023
Q2 | $261M | Buy |
|
|||||
|
2023
Q1 | $229M | Sell |
|
|||||
|
2022
Q4 | $220M | Sell |
|
|||||
|
2022
Q3 | $247M | Sell |
|
|||||
|
2022
Q2 | $290M | Sell |
|
|||||
|
2022
Q1 | $363M | Buy |
|
|||||
|
2021
Q4 | $396M | Sell |
|
|||||
|
2021
Q3 | $348M | Sell |
|
|||||
|
2021
Q2 | $329M | Sell |
|
|||||
|
2021
Q1 | $267M | Buy |
|
|||||
|
2020
Q4 | $258M | Sell |
|
|||||
|
2020
Q3 | $230M | Buy |
|
|||||
|
2020
Q2 | $197M | Buy |
|
|||||
|
2020
Q1 | $177M | Buy |
|
|||||
|
2019
Q4 | $212M | Buy |
|
|||||
|
2019
Q3 | $199M | Buy |
|
|||||
|
2019
Q2 | $152M | Buy |
|
|||||
|
2019
Q1 | $139M | Buy |
|
|||||
|
2018
Q4 | $103M | Buy |
|
|||||
|
2018
Q3 | $115M | Buy |
|
|||||
|
2018
Q2 | $92.7M | Buy |
|
|||||
|
2018
Q1 | $78.7M | Buy |
|
|||||
|
2017
Q4 | $56.4M | Buy |
|
|||||
|
2016
Q3 | – | Sell |
|
|||||
|
2016
Q2 | $15.9M | Sell |
|
|||||
|
2016
Q1 | $34.1M | Sell |
|
|||||
|
2015
Q4 | $32.9M | Sell |
|
|||||
|
2015
Q3 | $36.6M | Buy |
|
|||||
|
2015
Q2 | $36.2M | Buy |
|
|||||
|
2015
Q1 | $32M | Sell |
|
|||||
|
2014
Q4 | $38.3M | Sell |
|
|||||
|
2014
Q3 | $40.8M | Sell |
|
|||||
|
2014
Q2 | $40.2M | Sell |
|
|||||
|
2014
Q1 | $42.2M | Buy |
|
|||||
|
2013
Q4 | $30.6M | Buy |
|
|||||
|
2013
Q3 | $21.9M | Buy |
|
|||||
|
2013
Q2 | $18.6M | Buy |
|